Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous ex-vivo-expanded leucocytes treated with 5-aza-2’-deoxycytidine

EU orphan designation number: EU/3/13/1197   
Active ingredient: Autologous ex-vivo-expanded leucocytes treated with 5-aza-2’-deoxycytidine
Indication: Treatment of glioma
Sponsor: CytoVac A/S
Venlighedsvej 6, 2970 Hørsholm, Danmark

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Orphan designation EMA/OD/086/13 (2013)8042 of 13/11/2013